Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00882778 · ClinicalTrials.gov registry record
PROPACT: Retrospective Prophylaxis Patient Case Collection
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 86
- Enrollment target
NCT00882778: Completed study, sponsored by Novo Nordisk A/S.
NCT00882778 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 86 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00882778 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
This study is conducted in Europe and North and South America. The primary aim of this observational study is to evaluate the frequency and pattern of bleeding episodes in haemophilia patients receiving preventative treatment with activated recombinant human factor VII. The secondary aim is to evaluate which patients are selected for this treatment, the dose and dose intervals used, and the safety of activated recombinant human factor VII when used as prevention. The study also aims to increase understanding of the unmet medical need and clinical relevance of preventative treatment in haemophilia patients.
Primary Outcome
Percent change of bleeds per month in the pre-prophylaxis period and bleeds per month in the prophylaxis period
Interventions
- DRUG eptacog alfa (activated)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2009-04 |
| Est. Completion | 2010-05 |
What the finished NCT00882778 record still lists
NCT00882778 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 86 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which eptacog alfa (activated) is the first listed.
NCT00882778 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00882778 about?
NCT00882778 is a clinical study titled "PROPACT: Retrospective Prophylaxis Patient Case Collection". This study is conducted in Europe and North and South America. The primary aim of this observational study is to evaluate the frequency and pattern of bleeding episodes in haemophilia patients receiving preventative treatment with activated recombinant human factor VII. The secondary aim is to evalu...
What is the current status of trial NCT00882778?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2009-04. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00882778?
The interventions under investigation include: eptacog alfa (activated) (DRUG).
Who is sponsoring clinical trial NCT00882778?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia